98 related articles for article (PubMed ID: 7538330)
1. [Filgrastim in the treatment of severe neutropenia in a patient with bilobar pneumonia].
Marcos Sánchez F; Juárez Ucelay F; Plaza Díaz R; Durán Pérez-Navarro A
An Med Interna; 1995 Feb; 12(2):100-1. PubMed ID: 7538330
[No Abstract] [Full Text] [Related]
2. Low-dose filgrastim therapy for chronic neutropenia.
Kaczmarski RS; Mufti GJ
N Engl J Med; 1993 Oct; 329(17):1280-1. PubMed ID: 7692296
[No Abstract] [Full Text] [Related]
3. Acute lymphocytic leukemia after fulminant varicella associated with severe neutropenia.
Helft DA; Correa H; Rojas P; Warrier RP
South Med J; 2002 Sep; 95(9):1074-5. PubMed ID: 12356115
[TBL] [Abstract][Full Text] [Related]
4. Cost benefit and clinical efficacy of low-dose granulocyte colony-stimulating factor after standard chemotherapy in patients with non-Hodgkin's lymphoma.
Hashino S; Morioka M; Irie T; Shiroshita N; Kawamura T; Suzuki S; Iwasaki H; Umehara S; Kakinoki Y; Kurosawa M; Kahata K; Izumiyama K; Kobayashi H; Onozawa M; Takahata M; Fujisawa F; Kondo T; Asaka M
Int J Lab Hematol; 2008 Aug; 30(4):292-9. PubMed ID: 18665826
[TBL] [Abstract][Full Text] [Related]
5. G-CSF in the long-term treatment of cyclic neutropenia and chronic idiopathic neutropenia in adult patients.
Heussner P; Haase D; Kanz L; Fonatsch C; Welte K; Freund M
Int J Hematol; 1995 Dec; 62(4):225-34. PubMed ID: 8589368
[TBL] [Abstract][Full Text] [Related]
6. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
Cernelc P; Andoljsek D; Mlakar U; Pretnar J; Modic M; Zupan IP; Zver S
Pflugers Arch; 2000; 440(5 Suppl):R81-2. PubMed ID: 11005621
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of severe neutropenias in dogs and cats with filgrastim].
Kraft W; Kuffer M
Tierarztl Prax; 1995 Dec; 23(6):609-13. PubMed ID: 8585081
[TBL] [Abstract][Full Text] [Related]
8. Resolution of the neutropenia of Felty's syndrome by longterm administration of recombinant granulocyte colony stimulating factor.
Krishnaswamy G; Odem C; Chi DS; Kalbfleisch J; Baker N; Smith JK
J Rheumatol; 1996 Apr; 23(4):763-5. PubMed ID: 8730142
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
Bhana N
Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia.
Takeshita A; Saito H; Toyama K; Horiuchi A; Kuriya S; Furusawa S; Tsuruoka N; Takiguchi T; Matsuda T; Utsumi M; Shiku H; Matsui T; Egami K; Tamura K; Ohno R
Int J Hematol; 2000 Feb; 71(2):136-43. PubMed ID: 10745623
[TBL] [Abstract][Full Text] [Related]
11. Big cost savings from small filgrastim unit doses.
Sinsabaugh DK; Freyer DR
Am J Hosp Pharm; 1993 Jul; 50(7):1363-4. PubMed ID: 7689787
[No Abstract] [Full Text] [Related]
12. Filgrastim: new indication. AIDS-associated neutropenia: another soft indication.
Prescrire Int; 2001 Aug; 10(54):106-7. PubMed ID: 11718177
[TBL] [Abstract][Full Text] [Related]
13. [Colony stimulating factors in blood formation].
Goebel M
Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():51-6. PubMed ID: 7531048
[TBL] [Abstract][Full Text] [Related]
14. Dosage standardization for filgrastim.
Burke KW
Am J Hosp Pharm; 1992 Nov; 49(11):2698. PubMed ID: 1471628
[No Abstract] [Full Text] [Related]
15. Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF)--results of a prospective randomised monocentre study.
Bönig H; Silbermann S; Weller S; Kirschke R; Körholz D; Janssen G; Göbel U; Nürnberger W
Bone Marrow Transplant; 2001 Aug; 28(3):259-64. PubMed ID: 11535993
[TBL] [Abstract][Full Text] [Related]
16. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness of Leukostim, a Russian preparation of granulocyte colony-stimulating factor, in the treatment of chemotherapy-induced neutropenia in patients with malignant tumors].
Korman DB; Boronovskaia LE; Maslova IA; Andreeva EV; Seregina GV
Vopr Onkol; 2008; 54(5):639-42. PubMed ID: 19069482
[TBL] [Abstract][Full Text] [Related]
18. DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients.
Zappasodi P; Nosari AM; Astori C; Ciapanna D; Bonfichi M; Varettoni M; Mangiacavalli S; Morra E; Lazzarino M; Corso A
Transfusion; 2008 May; 48(5):857-60. PubMed ID: 18248573
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
Carlsson G; Ahlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
[TBL] [Abstract][Full Text] [Related]
20. The use of granulocyte colony-stimulating factor in the treatment of fever and neutropenia in a heart transplant patient.
Gordon MS; O'Donnell JA; Mohler ER; Cooper MA
J Heart Lung Transplant; 1993; 12(4):706-7. PubMed ID: 7690254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
